Form 4: ICU Medical Inc. Executive Ben Sousa Reports Stock Transactions
SEC Form 4 Filing
Ben Sousa, Chief Information Officer of ICU Medical Inc., reports the acquisition and disposal of common stock and restricted stock units on March 15, 2025.
Summary
- On March 15, 2025, Ben Sousa, the Chief Information Officer of ICU Medical Inc., reported transactions involving the company's stock.
- Sousa acquired 1,299 shares of common stock through the vesting of restricted stock units.
- He also disposed of 716 shares of common stock to cover tax obligations, at a price of $143.45 per share.
- Following these transactions, Sousa directly owns 2,479 shares of common stock and 1,300 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive, indicating a neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of key personnel and their sentiment towards the company's stock.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine stock management by an executive.
Key Dates
| Date | Description |
|---|---|
| 03/15/2025 | Date of stock transactions (acquisition and disposal). |
| 03/15/2025 | Vesting date for 1,299 Restricted Stock Units. |
| 03/15/2026 | Expiration date for derivative securities. |
| 03/17/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.